Gene · 2071
Papers2,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA Damage Response and Immune Defense. | Int J Mol Sci | 2020 | 33053746 | PubTator, text mining | PubMed |
| lncRNA involved in triptonide-induced cytotoxicity in mouse germ cells. | Reprod Toxicol | 2020 | 33045310 | PubTator, text mining | PubMed |
| Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data. | Target Oncol | 2020 | 33044685 | PubTator, text mining | PubMed |
| Evolutionary Study of Disorder in Protein Sequences. | Biomolecules | 2020 | 33036302 | PubTator, text mining | PubMed |
| Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma. | Clin Cancer Res | 2020 | 33028596 | PubTator, text mining | PubMed |
| Syndromic Inherited Retinal Diseases: Genetic, Clinical and Diagnostic Aspects. | Diagnostics (Basel) | 2020 | 33023209 | PubTator, text mining | PubMed |
| Focus on UV-Induced DNA Damage and Repair-Disease Relevance and Protective Strategies. | Int J Mol Sci | 2020 | 33019598 | PubTator, text mining | PubMed |
| RHOAming Through the Nucleotide Excision Repair Pathway as a Mechanism of Cellular Response Against the Effects of UV Radiation. | Front Cell Dev Biol | 2020 | 33015036 | PubTator, text mining | PubMed |
| Evaluation of Artificial Intelligence in Participating Structure-Based Virtual Screening for Identifying Novel Interleukin-1 Receptor Associated Kinase-1 Inhibitors. | Front Oncol | 2020 | 33014870 | PubTator, text mining | PubMed |
| The involvement of nucleotide excision repair proteins in the removal of oxidative DNA damage. | Nucleic Acids Res | 2020 | 33010169 | PubTator, text mining | PubMed |
| Envisioning how the prototypic molecular machine TFIIH functions in transcription initiation and DNA repair. | DNA Repair (Amst) | 2020 | 33007515 | PubTator, text mining | PubMed |
| Exploiting DNA repair defects in triple negative breast cancer to improve cell killing. | Ther Adv Med Oncol | 2020 | 32994807 | PubTator, text mining | PubMed |
| Targeted sequencing of crucial cancer causing genes of breast cancer in Saudi patients. | Saudi J Biol Sci | 2020 | 32994724 | PubTator, text mining | PubMed |
| Aging-Related Disorders and Mitochondrial Dysfunction: A Critical Review for Prospect Mitoprotective Strategies Based on Mitochondrial Nutrient Mixtures. | Int J Mol Sci | 2020 | 32992778 | PubTator, text mining | PubMed |
| Exosomes: Insights from Retinoblastoma and Other Eye Cancers. | Int J Mol Sci | 2020 | 32992741 | PubTator, text mining | PubMed |
| Structural basis of the XPB helicase-Bax1 nuclease complex interacting with the repair bubble DNA. | Nucleic Acids Res | 2020 | 32986831 | PubTator, text mining | PubMed |
| Ubiquitin and TFIIH-stimulated DDB2 dissociation drives DNA damage handover in nucleotide excision repair. | Nat Commun | 2020 | 32985517 | PubTator, text mining | PubMed |
| Use of a Topical Film-Forming Medical Device Containing Repairsomes® in a Patient with Xeroderma Pigmentosum to Avoid Progression to Skin Cancerization. | Clin Cosmet Investig Dermatol | 2020 | 32982361 | PubTator, text mining | PubMed |
| Conditional reprogramming: next generation cell culture. | Acta Pharm Sin B | 2020 | 32963937 | PubTator, text mining | PubMed |
| Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies. | Int J Mol Sci | 2020 | 32961800 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2071/papers?page=37